Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Clalit Health Services

Status and phase: Unknown; Phase 4

Conditions: Heart Failure

Treatments: Drug: erythropoietin

Study type: Interventional

Funder types: Other

Identifiers

NCT00418119

4273

Details and patient eligibility

About

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ischemic heart disease
• Systolic lv dysfunction
• Mild anemia
• Normal renal function
• Stable condition

Exclusion criteria

• Pregnancy
• Unstable condition
• Under 18 years old

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)